Table 1 Baseline demographics and clinical characteristics for the antidepressant and no antidepressants groups

Age (years) (mean ± SD)

29.56 ± 9.15

33.20 ± 13.29

U = 64.5, z = 0.82, p = 0.413

Illness duration (years) (mean ± SD)

14.16 ± 9.38

19.40 ± 14.13

U = 61.5, z = 0.98, p = 0.328

AN-R / AN-BP (n)

10 / 6

6 / 4

χ²(1) = 0.02, p = 0.899

BMI (kg/m²) (mean ± SD)

16.36 ± 1.50

15.95 ± 1.85

t(24) = −0.62, p = 0.540

EDE-Q Global (mean ± SD)

4.31 ± 0.82

3.64 ± 1.58

t(24) = − 1.45, p = 0.164

EDE-Q Restraint (mean ± SD)

4.20 ± 1.34

3.42 ± 1.86

t(24) = − 1.25, p = 0.225

EDE-Q Eating Concern (mean ± SD)

3.69 ± 0.80

3.28 ± 1.88

t(24) = − 0.77, p = 0.449

EDE-Q Shape Concern (mean ± SD)

4.83 ± 1.02

4.08 ± 1.68

U = 59, z = − 1.11, p = 0.266

EDE-Q Weight Concern (mean ± SD)

4.53 ± 0.98

3.78 ± 1.64

t(24) = − 1.46, p = 0.157

DASS-21 Total (mean ± SD)

74.00 ± 24.61

62.60 ± 29.33

t(24) = − 1.07, p = 0.296

DASS-21 Depression (mean ± SD)

29.13 ± 9.72

22.00 ± 10.71

t(24) = − 1.75, p = 0.093

DASS-21 Anxiety (mean ± SD)

17.38 ± 10.22

12.60 ± 10.96

t(24) = − 1.13, p = 0.865